Loews (NYSE: L) director awarded 235-share quarterly stock grant as compensation
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
HARRIS WALTER L reported acquisition or exercise transactions in this Form 4 filing.
Loews Corporation director Walter L. Harris received a quarterly stock grant of 235 shares of Common Stock as part of his board compensation. The shares were awarded at a stated price of $0.00 per share under the Loews Corporation 2025 Incentive Compensation Plan. Following this grant, Harris directly holds 25,063 Loews shares. This is a routine, compensation-related equity award rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
HARRIS WALTER L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 235 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 25,063 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Shares granted: 235 shares
Grant price: $0.00 per share
Shares held after grant: 25,063 shares
3 metrics
Shares granted
235 shares
Quarterly director stock grant
Grant price
$0.00 per share
Stated price for compensation award
Shares held after grant
25,063 shares
Director’s direct Loews holdings post-transaction
Key Terms
Incentive Compensation Plan, director compensation, Common Stock, quarterly grant
4 terms
Incentive Compensation Plan financial
"under the Loews Corporation 2025 Incentive Compensation Plan"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
director compensation financial
"in respect of director compensation under the Loews Corporation 2025"
Common Stock financial
"Represents quarterly grant of common stock in respect of director"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
quarterly grant financial
"Represents quarterly grant of common stock in respect of director"
FAQ
What did Loews (L) director Walter L. Harris report in this Form 4?
Loews director Walter L. Harris reported receiving a grant of 235 shares of Common Stock. The filing shows this was a compensation-related stock award, not an open-market trade, increasing his direct holdings to 25,063 shares after the transaction.
Was the Loews (L) Form 4 transaction a stock purchase or a compensation grant?
The transaction was a compensation grant, not a market purchase. The Form 4 labels it as a grant or award acquisition, with 235 Common Stock shares issued at a stated price of $0.00 per share as part of director compensation.
What is the size of the stock grant reported by Loews (L) director Walter L. Harris?
The stock grant totals 235 shares of Loews Common Stock. This is a relatively small, routine equity award made quarterly as part of director compensation, rather than a large discretionary trade or significant change in ownership position.
Under which plan was the Loews (L) director stock grant made?
The stock grant was made under the Loews Corporation 2025 Incentive Compensation Plan. The footnote explains it represents a quarterly grant of Common Stock given as part of director compensation, indicating a regular, structured equity award program.
Did the Loews (L) Form 4 involve any derivative securities or stock options?
The Form 4 does not report any derivative securities or stock options. It shows only a non-derivative Common Stock grant of 235 shares, with no associated exercise price, expiration date, or remaining derivative position disclosed in the filing.